GL261-Luc Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | GL261-Luc cells are a bioluminescent derivative of the murine GL261 glioma cell line engineered to stably express a luciferase reporter gene. Following administration of the luciferin substrate, these cells emit a quantifiable luminescent signal proportional to viable tumor cell number, enabling sensitive and non-invasive monitoring of tumor growth and therapeutic response. GL261-Luc cells retain many of the biological and immunogenic properties of the parental GL261 glioma model, including aggressive growth behavior and compatibility with syngeneic immunocompetent mouse models. Because the parental GL261 line originates from murine glioma, GL261-Luc cells are particularly valuable for studying glioblastoma biology in the context of an intact immune system. GL261-Luc cells are extensively used in orthotopic intracranial and subcutaneous glioma models for longitudinal in vivo bioluminescence imaging. The stable luciferase expression enables real-time assessment of tumor establishment, progression, invasion, recurrence, and response to therapy without requiring invasive procedures at multiple time points. These cells are widely applied in preclinical neuro-oncology research evaluating chemotherapeutics, radiation therapy, immune checkpoint blockade, CAR-T cell therapies, cancer vaccines, oncolytic viruses, and nanoparticle-based drug delivery systems. In vitro, GL261-Luc cells are also suitable for viability assays, cytotoxicity testing, migration and invasion studies, and high-throughput therapeutic screening workflows using luminescence-based readouts. As a syngeneic glioma model, GL261-Luc cells are particularly important for investigating tumor-immune interactions, neuroinflammation, and mechanisms of immune evasion within the glioblastoma microenvironment. However, luciferase vector systems, promoter configurations, and selection strategies may differ between independently generated variants, potentially affecting signal intensity and long-term reporter stability. Researchers should therefore validate luciferase activity, growth kinetics, and immunologic characteristics under their specific experimental conditions prior to use in quantitative imaging studies or therapeutic evaluation. |
|---|---|
| Organism | Mouse |
| Tissue | Brain |
| Disease | Glioblastoma |
Characteristics
| Breed/Subspecies | C57BL/6 |
|---|---|
| Growth properties | Adherent |
Regulatory Data
| Citation | GL-261-Luc (Cytion catalog number 305662) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_C9CB |
| GMO Status | GMO-S1: This murine GL261 glioma line contains a lentiviral-Luc cassette for bioluminescence tracking of tumor progression. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Protein expression | Luc |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 to 3 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305662-160426 | Certificate of Analysis | 22. May. 2026 | 305662 |